Sign in

Matteo Fiorenza

@matteo-fiorenza.bsky.social
510 followers 300 following 27 posts

Assistant Professor in Clinical Translational Metabolism at the University of Copenhagen | #Physiology #Metabolism #Mitochondria #Diabetes #Obesity #Exercise #Muscle

PostsRepliesMedia
Matteo Fiorenza @matteo-fiorenza.bsky.social · 04/06/2026
📄Preprint update By integrating cross-sectional phenotyping with an #exercise intervention in a human genetic model of mitochondrial dysfunction linked to #diabetes, we define an exercise-modifiable mitochondrial basis for muscle insulin resistance. www.medrxiv.org/content/10.6...
010
Matteo Fiorenza @matteo-fiorenza.bsky.social · 26/01/2026
Physical #Fitness with #Exercise and #GLP1 Receptor Agonist Treatment Alone or Combined After Diet-Induced #WeightLoss: A Secondary Analysis of a Randomized Controlled Trial in Adults with #Obesity Our latest publication in Sports Medicine
link.springer.com
Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity - Spo...
Background Obesity is associated with impaired physical fitness, including physical functional performance and cardiorespiratory fitness, which affect health-related quality of life and mortality. Obj...
010
Matteo Fiorenza @matteo-fiorenza.bsky.social · 05/01/2026
Physiological and molecular characterization of individuals carrying a diabetogenic mtDNA mutation establishes a mitochondrial basis for insulin resistance in humans 👇Check out our preprint on @medrxivpreprint.bsky.social 💬Comments and feedback are very welcome
tinyurl.com
Physiological and molecular characterization of individuals carrying a diabetogenic mtDNA mutation establishes a mitochondrial basis for insulin resistance in humans
Mitochondrial dysfunction has long been associated with insulin resistance, yet the causal relationship in humans remains unresolved. Here, we leveraged individuals carrying the diabetogenic m.3243A>G...
000
Matteo Fiorenza @matteo-fiorenza.bsky.social · 22/12/2025
📄 New preprint Using deep physiological and molecular phenotyping in individuals carrying a diabetogenic mtDNA mutation, we probe whether, which, and how mitochondrial defects drive insulin resistance in humans. 👇 Link in first comment #Physiology #Diabetes #Mitochondria #Metabolism
122
Matteo Fiorenza @matteo-fiorenza.bsky.social · 19/09/2025
✨Proud moment at #EASD2025 Tue L. Nielsen presented our MITO-DYS-IR study results in the plenary hall, uncovering the causal role of #muscle #mitochondrial defects in #diabetes pathophysiology Grateful to our collaborators and @easdnews.bsky.social Early Career Academy for the Best Abstract Award
020
Matteo Fiorenza @matteo-fiorenza.bsky.social · 16/09/2025
If you’re at #EASD2025 and interested in potential mechanisms that protect against obesity, don’t miss: “LBA SO 02 – Thinking Big About Treating Obesity” 📍 Short Oral Station 23 (Hall C) 📅 Tuesday, 16 Sept ⏰ 13:15 @easdnews.bsky.social
030
Reposted by Matteo Fiorenza
Eric Topol @erictopol.bsky.social · 17/07/2025
A big day for preventing mitochondrial diseases from transmitting to the next generation www.nature.com/articles/d41... www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10....
215743
Reposted by Matteo Fiorenza
Daniel Drucker @danieljdrucker.bsky.social · 26/03/2025
Here it is proposed that halofuginone, a FDA–approved anti-scleroderma and antiprotozoal drug, is a promising anti-#obesity agent acting via FGF-21 and GDF-15 in preclinical mouse and pig models www.science.org/doi/10.1126/...
science.org
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21
Halofuginone curbs weight gain in mice and pigs.
133
Reposted by Matteo Fiorenza
Matteo Fiorenza @matteo-fiorenza.bsky.social · 20/11/2024
Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans In our latest study, we provide mechanistic evidence implicating mitochondrial ROS in the development of muscle insulin resistance in hyperlipidemic states such as obesity. 1/7 🧵👇
science.org
Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans
Selective targeting of mitochondrial oxidative stress mitigates lipid-induced insulin resistance in humans.
1288
Matteo Fiorenza @matteo-fiorenza.bsky.social · 06/01/2025
Kicking off 2025 with a highlight from our 2024 study in #CellReportsMedicine @cellpress.bsky.social We uncovered the potential role of a metabokine-sphingolipid axis in sustaining weight loss in humans with #obesity. 1/10 🧵👇
cell.com
Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids
Fiorenza et al. reveal selective and dynamic alterations in energy-balance-regulating metabokines and sphingolipids throughout weight loss, weight-loss maintenance, and weight regain in adults with obesity. Weight-loss maintenance elicits distinct remodeling patterns within the FGF21-adiponectin-leptin-sphingolipid axis as compared with weight regain, and these changes are associated with cardiometabolic health outcomes.
130
Reposted by Matteo Fiorenza
John Speakman @johnspeakman4.bsky.social · 21/11/2024
Views about the causes of obesity have polarised. Characterised by low carb and energy balance models. Last year NovoNordisk invited the protagonists of these models to Copenhagen to discuss commonalities and differences. The resultant paper has now been published in Nature Metabolism rdcu.be/dZryb
rdcu.be
On the pathogenesis of obesity: causal models and missing pieces of the puzzle
Nature Metabolism - This authoritative Perspective lays a foundation for the field of obesity research by comparing commonalities and differences between competing models of obesity pathogenesis...
07925
Matteo Fiorenza @matteo-fiorenza.bsky.social · 20/11/2024
Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans In our latest study, we provide mechanistic evidence implicating mitochondrial ROS in the development of muscle insulin resistance in hyperlipidemic states such as obesity. 1/7 🧵👇
science.org
Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans
Selective targeting of mitochondrial oxidative stress mitigates lipid-induced insulin resistance in humans.
1288
Reposted by Matteo Fiorenza
Eric Topol @erictopol.bsky.social · 18/11/2024
A mechanism for why durable weight loss is so difficult: epigenetic memory of fat cells www.nature.com/articles/s41...
17547124
Matteo Fiorenza @matteo-fiorenza.bsky.social · 18/11/2024
Hello @bsky.app #science community! I'll be sharing papers on #physiology, #metabolism, #diabetes, #obesity, #mitochondria, #muscle, and #exercise. If you are working in these areas, reach out and connect.
031
Reposted by Matteo Fiorenza
Katsu Funai @katsufunai.bsky.social · 16/11/2024
New preprint! We show that GLP1RA semaglutide increases skeletal muscle OXPHOS efficiency in mice. Improved energy efficiency would be predicted to lower energy expenditure and may contribute to propensity for weight regain. www.biorxiv.org/content/10.1...
biorxiv.org
Semaglutide-induced weight loss improves mitochondrial energy efficiency in skeletal muscle
Objective: Glucagon-like peptide 1 receptor agonists (e.g. semaglutide) potently induce weight loss and thereby reducing obesity-related complications. However, weight regain occurs when treatment is ...
2259
Reposted by Matteo Fiorenza
Christian Frezza @frezzalab.bsky.social · 13/11/2024
People working on #cancermetabolism, #mitochondrialbiology, #metabolism, please reach out! Share this so I can follow who is here! I will share paper on cancer metabolism, but anything else related to mitochondria and metabolism.
media.tenor.com
a bald man in a blue suit is making a funny face and pointing at something .
ALT: a bald man in a blue suit is making a funny face and pointing at something .
68142